13D Filing: Novo A/s and Htg Molecular Diagnostics Inc (NASDAQ:HTGM)

Page 4 of 4

Page 4 of 4 – SEC Filing


SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true,
complete and correct.

Dated: March 31, 2017 Novo A/S
/s/ Peter Haahr
By: Peter Haahr
Its: Chief Financial Officer

Signature Page to Schedule 13D

Reporting Person: Novo A/S Issuer: HTG Molecular Diagnostics, Inc.

Follow Htg Molecular Diagnostics Inc (NASDAQ:HTGM)

Page 4 of 4